Cardiology

Toronto, Ontario, Canada, September 23, 2026 Cardiol Therapeutics has announced that its pivotal Phase III MAVERIC clinical trial evaluating...

MONTREAL and CHARLOTTE, N.C. — September 24, 2026 Milestone Pharmaceuticals Inc. announced that the Montreal Heart Institute has enrolled...

Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...

Rehovot, Israel, September 18, 2026 CardiaCare, a medical device company developing wearable technology for cardiac arrhythmias, has announced the...

Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...

Basel, Switzerland, September 18, 2026 Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...

Boston, Massachusetts, U.S., September 18, 2026 ZBeats, a digital health and medical technology company focused on cardiac diagnostics, has...

BERLIN — September 9, 2026 Bayer announced the initiation of a global Phase II clinical trial of BAY 3670549,...

Dallas, Texas, August 29, 2026 Vesalio announced positive results from the NATURE randomized controlled trial, evaluating the company’s enVast™...

Tenax Therapeutics, Chapel Hill, North Carolina, August 29, 2026 Tenax Therapeutics announced the presentation of additional Phase 3 LEVEL...